Changes in these parameters, such as a decrease in tPA and an increase in PAI-1 levels, have been reported in patients with depression, neurosis, and chronic stress [253,254], and recent studies show that tPA and PAI-1 levels can be reliable markers of major depressive disorder (MDD). This evidence concerns the gene SERPINE1 and depressive symptom measurement.